Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1992 1
1993 1
1997 1
1998 1
1999 2
2001 1
2002 3
2003 4
2004 1
2005 2
2006 1
2007 3
2008 6
2009 5
2011 2
2012 6
2013 12
2014 6
2015 3
2016 1
2018 2
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25590727

64 results
Results by year
Filters applied: . Clear all
Page 1
Soluble fractalkine in the plasma of fibromyalgia patients.
Garcia JJ, Ortega E. Garcia JJ, et al. An Acad Bras Cienc. 2014 Dec;86(4):1915-7. doi: 10.1590/0001-3765201420130081. Epub 2014 Dec 9. An Acad Bras Cienc. 2014. PMID: 25590727 Free article.
Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
Kim TS, Lim HK, Lee JY, Kim DJ, Park S, Lee C, Lee CU. Kim TS, et al. Neurosci Lett. 2008 May 9;436(2):196-200. doi: 10.1016/j.neulet.2008.03.019. Epub 2008 Mar 13. Neurosci Lett. 2008. PMID: 18378084
Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity.
Suzuki F, Kubota T, Miyazaki Y, Ishikawa K, Ebisawa M, Hirohata S, Ogura T, Mizusawa H, Imai T, Miyasaka N, Nanki T. Suzuki F, et al. Arthritis Res Ther. 2012 Mar 6;14(2):R48. doi: 10.1186/ar3761. Arthritis Res Ther. 2012. PMID: 22394569 Free PMC article.
Serum fractalkine and interferon-gamma inducible protein-10 concentrations are early detection markers for acute renal allograft rejection.
Zhang Q, Liu YF, Su ZX, Shi LP, Chen YH. Zhang Q, et al. Transplant Proc. 2014 Jun;46(5):1420-5. doi: 10.1016/j.transproceed.2014.02.019. Transplant Proc. 2014. PMID: 24935307
Fractalkine is an independent predictor of mortality in patients with advanced heart failure.
Richter B, Koller L, Hohensinner PJ, Rychli K, Zorn G, Goliasch G, Berger R, Mörtl D, Maurer G, Huber K, Pacher R, Wojta J, Hülsmann M, Niessner A. Richter B, et al. Thromb Haemost. 2012 Dec;108(6):1220-7. doi: 10.1160/TH12-03-0195. Epub 2012 Sep 26. Thromb Haemost. 2012. PMID: 23014777 Clinical Trial.
Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report.
Yao K, Lu H, Huang R, Zhang S, Hong X, Shi H, Sun A, Qian J, Zou Y, Ge J. Yao K, et al. Cardiovasc Diabetol. 2011 Jun 10;10:50. doi: 10.1186/1475-2840-10-50. Cardiovasc Diabetol. 2011. PMID: 21658276 Free PMC article.
Fractalkine and TGF-beta1 levels reflect the severity of chronic pancreatitis in humans.
Yasuda M, Ito T, Oono T, Kawabe K, Kaku T, Igarashi H, Nakamura T, Takayanagi R. Yasuda M, et al. World J Gastroenterol. 2008 Nov 14;14(42):6488-95. doi: 10.3748/wjg.14.6488. World J Gastroenterol. 2008. PMID: 19030200 Free PMC article.
Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients.
Hoogendijk AJ, Wiewel MA, van Vught LA, Scicluna BP, Belkasim-Bohoudi H, Horn J, Zwinderman AH, Klein Klouwenberg PM, Cremer OL, Bonten MJ, Schultz MJ, van der Poll T; MARS consortium. Hoogendijk AJ, et al. Crit Care. 2015 Nov 25;19:412. doi: 10.1186/s13054-015-1125-0. Crit Care. 2015. PMID: 26603530 Free PMC article.
Hypertrophy of the ligament flavum in degenerative lumbar stenosis associated with the increased expression of fractalkine (CX3CL1)/CX3CR1 chemokine.
Oh IS, Suh DW, Ha KY. Oh IS, et al. Connect Tissue Res. 2013;54(6):380-5. doi: 10.3109/03008207.2013.848199. Connect Tissue Res. 2013. PMID: 24060055
Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation.
Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS. Fevang B, et al. Clin Immunol. 2009 Feb;130(2):151-61. doi: 10.1016/j.clim.2008.09.002. Epub 2008 Oct 19. Clin Immunol. 2009. PMID: 18938112
64 results
Jump to page